MEDIAN TECHNOLOGIES (EPA:ALMDT) | WebDisclosure

Basculer en Français

8611	Companies
141742	Keywords
77650	Articles
75757	Press releases

Home
Companies
MEDIAN TECHNOLOGIES

BRIEF

published on 03/14/2025 at 17:50, 30 days 10 hours ago

Median Technologies Maintains its Eligibility for the PEA-PME Scheme

PEA-PME Euronext Growth Tax Benefits Eligibility Median Technologies
BRIEF

published on 03/14/2025 at 17:50, 30 days 10 hours ago

Median Technologies Maintient son Éligibilité au Dispositif PEA-PME

PEA-PME Euronext Growth Éligibilité Avantages Fiscaux Median Technologies
PRESS RELEASE

published on 03/14/2025 at 17:45, 30 days 10 hours ago

Etat membre d'origine / Choix de l’autorité compétente pour le contrôle de l’information réglementée
Median Technologies confirms eligibility for the PEA-PME scheme, meeting criteria of <5,000 employees and annual turnover <1.5 billion euros. Shares remain in PEA-PME accounts with tax benefits

Eligibility Criteria Tax Advantages Median Technologies PEA-PME Scheme Stock Savings Plan
BRIEF

published on 02/24/2025 at 17:50, 1 month 17 days ago

Median Technologies : Présentation d'eyonis™ LCS à l'ECR 2025

Intelligence Artificielle Median Technologies Cancer Du Poumon Eyonis™ LCS ECR 2025
BRIEF

published on 02/24/2025 at 17:50, 1 month 17 days ago

Median Technologies: Presentation of eyonis™ LCS at ECR 2025

Artificial Intelligence Median Technologies Lung Cancer Eyonis™ LCS ECR 2025
PRESS RELEASE

published on 02/24/2025 at 17:45, 1 month 17 days ago

Informations privilégiées / Autres communiqués
Median Technologies présentera eyonis™ LCS, logiciel IA pour dépistage cancer poumon, à l’ECR. Validation clinique réussie. Dossiers réglementaires soumis bientôt

IA Dépistage Median Technologies Cancer Du Poumon Eyonis LCS
BRIEF

published on 01/31/2025 at 08:05, 2 months 13 days ago

Median Technologies dévoile ses résultats financiers 2024 et ses perspectives 2025

Résultats Financiers Median Technologies Eyonis™ LCS FDA Approbation Expansion 2025
BRIEF

published on 01/31/2025 at 08:05, 2 months 13 days ago

Median Technologies unveils its 2024 financial results and its 2025 outlook

Financial Results FDA Approval Median Technologies Eyonis™ LCS Expansion 2025
PRESS RELEASE

published on 01/31/2025 at 08:00, 2 months 13 days ago

Informations privilégiées / Autres communiqués
Median Technologies communique ses indicateurs financiers clés 2024 et perspectives 2025, incluant des avancées sur eyonis™ LCS pour le dépistage du cancer du poumon

Indicateurs Financiers Median Technologies Cancer Du Poumon Eyonis LCS Perspectives 2025
PRESS RELEASE

published on 01/31/2025 at 08:00, 2 months 13 days ago

Inside Information / Other news releases
Median Technologies reports 2024 financial indicators and 2025 outlook, including eyonis™ LCS FDA clearance and iCRO revenue growth. Strategic milestones and new financing agreements drive towards 2025 goals

Financial Indicators Median Technologies Eyonis LCS 2025 Outlook ICRO Revenue Growth

1 2 ... 6

Accesswire

Published on 04/12/2025 at 15:45, 1 day 12 hours ago

New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CFO Julia Qian, BIOVie’s Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice Presid
Published on 04/12/2025 at 02:00, 2 days 2 hours ago

Battery X Metals Announces Provisional Patent Application with United States Patent & Trademark Office for Lithium-Ion Battery Rebalancing Technology Innovations
Published on 04/12/2025 at 00:10, 2 days 4 hours ago

Applied Minerals, Inc. Files Motion to Approve Disclosure Statement
Published on 04/12/2025 at 00:00, 2 days 4 hours ago

Ur-Energy Releases 2024 Year End Results
Published on 04/11/2025 at 23:45, 2 days 4 hours ago

Gold Terra Closes First Tranche of Financing Package with Support from Osisko Gold Royalties

View all ACCESSWIRE

EQS Group

Published on 04/11/2025 at 21:45, 2 days 6 hours ago

OPPO Unveils Agentic AI Initiative at Google Cloud Next 2025, Showcasing Innovations and Leadership in AI Experiences
Published on 04/11/2025 at 18:40, 2 days 9 hours ago

AGM 2025 - Bossard Holding AG Press Release
Published on 04/11/2025 at 18:38, 2 days 9 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/11/2025 at 18:23, 2 days 9 hours ago

EQS-Adhoc: Cherry SE: Cherry SE recognizes asset impairment for 2024; updates adjusted EBITDA margin for fiscal year 2024
Published on 04/11/2025 at 18:10, 2 days 10 hours ago

Kaufman & Broad SA: 2025, 1ST QUARTER RESULTS

Les Echos

Published on 04/11/2025 at 18:30, 2 days 9 hours ago

Reclassification of shares within the Feuillet family concert with no impact on the control of the company
Published on 04/11/2025 at 18:30, 2 days 9 hours ago

Reclassement d'actions au sein du concert familial Feuillet sans incidence sur le contrôle de la société
Published on 04/11/2025 at 18:00, 2 days 10 hours ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/03/2025
Published on 04/11/2025 at 18:00, 2 days 10 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/03/2025
Published on 04/11/2025 at 17:50, 2 days 10 hours ago

Mise à disposition du Rapport Financier Annuel 2024

View all LES ECHOS COMFI WIRE